1. Home
  2. TEVA vs CAVA Comparison

TEVA vs CAVA Comparison

Compare TEVA & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • CAVA
  • Stock Information
  • Founded
  • TEVA 1901
  • CAVA 2006
  • Country
  • TEVA Israel
  • CAVA United States
  • Employees
  • TEVA N/A
  • CAVA N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • CAVA Restaurants
  • Sector
  • TEVA Health Care
  • CAVA Consumer Discretionary
  • Exchange
  • TEVA Nasdaq
  • CAVA Nasdaq
  • Market Cap
  • TEVA 19.2B
  • CAVA 16.2B
  • IPO Year
  • TEVA N/A
  • CAVA 2023
  • Fundamental
  • Price
  • TEVA $17.12
  • CAVA $144.87
  • Analyst Decision
  • TEVA Strong Buy
  • CAVA Buy
  • Analyst Count
  • TEVA 8
  • CAVA 13
  • Target Price
  • TEVA $19.63
  • CAVA $144.77
  • AVG Volume (30 Days)
  • TEVA 7.8M
  • CAVA 3.5M
  • Earning Date
  • TEVA 11-06-2024
  • CAVA 11-12-2024
  • Dividend Yield
  • TEVA N/A
  • CAVA N/A
  • EPS Growth
  • TEVA N/A
  • CAVA N/A
  • EPS
  • TEVA N/A
  • CAVA 0.46
  • Revenue
  • TEVA $16,772,000,000.00
  • CAVA $913,488,000.00
  • Revenue This Year
  • TEVA $4.70
  • CAVA $31.31
  • Revenue Next Year
  • TEVA $4.47
  • CAVA $21.34
  • P/E Ratio
  • TEVA N/A
  • CAVA $309.10
  • Revenue Growth
  • TEVA 9.81
  • CAVA 34.05
  • 52 Week Low
  • TEVA $9.35
  • CAVA $31.47
  • 52 Week High
  • TEVA $19.31
  • CAVA $172.43
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 44.64
  • CAVA 59.23
  • Support Level
  • TEVA $16.15
  • CAVA $137.27
  • Resistance Level
  • TEVA $17.17
  • CAVA $143.08
  • Average True Range (ATR)
  • TEVA 0.49
  • CAVA 7.92
  • MACD
  • TEVA -0.04
  • CAVA -0.21
  • Stochastic Oscillator
  • TEVA 30.54
  • CAVA 31.08

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.

Share on Social Networks: